FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994870955> ?p ?o ?g. }

• W2994870955 endingPage "711" @default.
• W2994870955 startingPage "706" @default.
• W2994870955 abstract "Cisplatin (Cis-DDP) is one of the most widely used anti-cancer drugs. It is applicable to many types of cancer, including lung, bladder, and breast cancer. However, its use is now limited because of drug resistance. p90 ribosomal S6 kinase (p90RSK) is one of the downstream effectors in the extracellular signalregulated protein kinases 1 and 2 (ERK1/2) pathway and high expression of p90RSK is observed in human breast cancer tissues. Therefore, we investigated the role of p90RSK in the Cis-DDP resistance-related signaling pathway and epithelialmesenchymal transition (EMT) in breast cancer cells. First, we discovered that MDA-MB-231 cells exhibited more Cis-DDP resistance than other breast cancer cells, including MCF-7 and BT549 cells. Cis-DDP increased p90RSK activation, whereas the inactivation of p90RSK using a small interfering RNA (siRNA) or dominant-negative kinase mutant plasmid overexpression significantly reduced Cis-DDP-induced cell proliferation and migration via the inhibition of matrix metallopeptidase (MMP)2 and MMP9 in MDA-MB-231 cells. In addition, p90RSK activation was involved in EMT via the upregulation of mRNA expression, including that of Snail, Twist, ZEB1, N-cadherin, and vimentin. We also investigated NF-κB, the upstream regulator of EMT markers, and discovered that Cis-DDP treatment led to NF-κB translocation in the nucleus as well as its promoter activity. Our results suggest that targeting p90RSK would be a good strategy to increase Cis-DDP sensitivity in triple-negative breast cancers. [BMB Reports 2019; 52(12): 706-711]." @default.
• W2994870955 created "2019-12-26" @default.
• W2994870955 creator A5005119534 @default.
• W2994870955 creator A5020567048 @default.
• W2994870955 creator A5036364665 @default.
• W2994870955 creator A5062377822 @default.
• W2994870955 creator A5082704915 @default.
• W2994870955 date "2019-12-31" @default.
• W2994870955 modified "2023-10-17" @default.
• W2994870955 title "Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT" @default.
• W2994870955 cites W1963766715 @default.
• W2994870955 cites W1987604182 @default.
• W2994870955 cites W2083990797 @default.
• W2994870955 cites W2089704952 @default.
• W2994870955 cites W2110210715 @default.
• W2994870955 cites W2118433927 @default.
• W2994870955 cites W2125052450 @default.
• W2994870955 cites W2154282262 @default.
• W2994870955 cites W2342445953 @default.
• W2994870955 cites W2510331075 @default.
• W2994870955 cites W2528042461 @default.
• W2994870955 cites W2544538072 @default.
• W2994870955 cites W2749467817 @default.
• W2994870955 cites W2756269835 @default.
• W2994870955 cites W2766224815 @default.
• W2994870955 cites W2794817947 @default.
• W2994870955 cites W2799345656 @default.
• W2994870955 cites W2859332285 @default.
• W2994870955 cites W2884360566 @default.
• W2994870955 cites W2888883654 @default.
• W2994870955 cites W2894552299 @default.
• W2994870955 cites W2895974669 @default.
• W2994870955 cites W2917909413 @default.
• W2994870955 cites W2924251124 @default.
• W2994870955 cites W2945705826 @default.
• W2994870955 doi "https://doi.org/10.5483/bmbrep.2019.52.12.234" @default.
• W2994870955 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6941763" @default.
• W2994870955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31818359" @default.
• W2994870955 hasPublicationYear "2019" @default.
• W2994870955 type Work @default.
• W2994870955 sameAs 2994870955 @default.
• W2994870955 citedByCount "14" @default.
• W2994870955 countsByYear W29948709552020 @default.
• W2994870955 countsByYear W29948709552021 @default.
• W2994870955 countsByYear W29948709552022 @default.
• W2994870955 countsByYear W29948709552023 @default.
• W2994870955 crossrefType "journal-article" @default.
• W2994870955 hasAuthorship W2994870955A5005119534 @default.
• W2994870955 hasAuthorship W2994870955A5020567048 @default.
• W2994870955 hasAuthorship W2994870955A5036364665 @default.
• W2994870955 hasAuthorship W2994870955A5062377822 @default.
• W2994870955 hasAuthorship W2994870955A5082704915 @default.
• W2994870955 hasBestOaLocation W29948709551 @default.
• W2994870955 hasConcept C104317684 @default.
• W2994870955 hasConcept C121608353 @default.
• W2994870955 hasConcept C126322002 @default.
• W2994870955 hasConcept C127561419 @default.
• W2994870955 hasConcept C184235292 @default.
• W2994870955 hasConcept C185592680 @default.
• W2994870955 hasConcept C2776694085 @default.
• W2994870955 hasConcept C2778239845 @default.
• W2994870955 hasConcept C2780110267 @default.
• W2994870955 hasConcept C2780926556 @default.
• W2994870955 hasConcept C502942594 @default.
• W2994870955 hasConcept C530470458 @default.
• W2994870955 hasConcept C55493867 @default.
• W2994870955 hasConcept C62112901 @default.
• W2994870955 hasConcept C71924100 @default.
• W2994870955 hasConcept C76419328 @default.
• W2994870955 hasConcept C86803240 @default.
• W2994870955 hasConcept C87325107 @default.
• W2994870955 hasConcept C95444343 @default.
• W2994870955 hasConcept C96232424 @default.
• W2994870955 hasConcept C97029542 @default.
• W2994870955 hasConceptScore W2994870955C104317684 @default.
• W2994870955 hasConceptScore W2994870955C121608353 @default.
• W2994870955 hasConceptScore W2994870955C126322002 @default.
• W2994870955 hasConceptScore W2994870955C127561419 @default.
• W2994870955 hasConceptScore W2994870955C184235292 @default.
• W2994870955 hasConceptScore W2994870955C185592680 @default.
• W2994870955 hasConceptScore W2994870955C2776694085 @default.
• W2994870955 hasConceptScore W2994870955C2778239845 @default.
• W2994870955 hasConceptScore W2994870955C2780110267 @default.
• W2994870955 hasConceptScore W2994870955C2780926556 @default.
• W2994870955 hasConceptScore W2994870955C502942594 @default.
• W2994870955 hasConceptScore W2994870955C530470458 @default.
• W2994870955 hasConceptScore W2994870955C55493867 @default.
• W2994870955 hasConceptScore W2994870955C62112901 @default.
• W2994870955 hasConceptScore W2994870955C71924100 @default.
• W2994870955 hasConceptScore W2994870955C76419328 @default.
• W2994870955 hasConceptScore W2994870955C86803240 @default.
• W2994870955 hasConceptScore W2994870955C87325107 @default.
• W2994870955 hasConceptScore W2994870955C95444343 @default.
• W2994870955 hasConceptScore W2994870955C96232424 @default.
• W2994870955 hasConceptScore W2994870955C97029542 @default.
• W2994870955 hasFunder F4320322120 @default.
• W2994870955 hasIssue "12" @default.
• W2994870955 hasLocation W29948709551 @default.

• next